Cargando…

P12-15. Replication enhancement of an alphaviral-lentiviral replicating chimeric particle (RCP) vaccine

Detalles Bibliográficos
Autores principales:	Young, K, Beard, C, Johnston, R
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767672/ http://dx.doi.org/10.1186/1742-4690-6-S3-P181

Ejemplares similares

Role of Pentraxin 3 in Shaping Arthritogenic Alphaviral Disease: From Enhanced Viral Replication to Immunomodulation
por: Foo, Suan-Sin, et al.
Publicado: (2015)

Correction: Role of Pentraxin 3 in Shaping Arthritogenic Alphaviral Disease: From Enhanced Viral Replication to Immunomodulation
Publicado: (2015)

Chondrocytes Contribute to Alphaviral Disease Pathogenesis as a Source of Virus Replication and Soluble Factor Production
por: Lim, Elisa X. Y., et al.
Publicado: (2018)

Phase I study of alphaviral vector (AVX701) in colorectal cancer patients: comparison of immune responses in stage III and stage IV patients
por: Morse, Michael A, et al.
Publicado: (2015)

Roles for endocytosis in lentiviral replication
por: Marsh, Mark, et al.
Publicado: (1997)

P03-11. DNA vaccination with IL-12 lowers viral replication following SIVmac251 challenge
por: Hirao, LA, et al.
Publicado: (2009)

Development of replication-competent adenovirus based vaccine vectors
por: Abbink, P, et al.
Publicado: (2012)

Evaluation of a replication-competent VSV-SIV vaccine candidate
por: Jurgens, CK, et al.
Publicado: (2012)

P12-07. Novel HIV vaccines using chimeric influenza HA vectors
por: Steinhauer, DA, et al.
Publicado: (2009)

P14-15 LB. The safety and immunogenicity of HIV-1 vaccines based on DNA and replication competent vaccinia vector in phase I clinical trial
por: Shao, Y, et al.
Publicado: (2009)

P19-19. MVA vaccines are efficiently cross-presented by DCs and do not enhance HIV replication in DC/T cell cultures
por: Brandler, S, et al.
Publicado: (2009)

P03-01. The relationship of envelope evolution to lentiviral persistence and vaccine efficacy
por: Craigo, JK, et al.
Publicado: (2009)

Design and development of a new lentiviral based anti-HIV therapeutic vaccine
por: Rodriguez, M, et al.
Publicado: (2012)

P09-11. Reduced replication capacity of NL4-3 chimeric viruses encoding RT-Integrase sequences from HIV-1 elite controllers
por: Li, C, et al.
Publicado: (2009)

Role of innate signalling pathways in the immunogenicity of alphaviral replicon-based vaccines
por: Näslund, Tanja I, et al.
Publicado: (2011)

Simian immunodeficiency virus-Vpx as an adjuvant for integrase defective lentiviral vector-based vaccines
por: Blasi, M, et al.
Publicado: (2012)

Mucosal prime with a replicating vaccinia-based vaccine promotes mucosal immunity against SIV
por: Tang, X, et al.
Publicado: (2012)

P17-20. Lentiviral vector-based vaccine against SIV infection and simian AIDS
por: Beignon, A, et al.
Publicado: (2009)

Mutational analysis of H5N1 hemagglutinins: identification of molecular determinants for efficient packaging into pseudotyped lentiviral particles
por: Tang, DJ, et al.
Publicado: (2011)

Dendritic cell nediated inhibition of lentiviral infection
por: Drake, A, et al.
Publicado: (2012)

P19-40. Different forms of a lentiviral glycoprotein presented by bivalent measles virus vaccines
por: Heidmeier, S, et al.
Publicado: (2009)

Do humans have replication-competent endogenous retroviruses?
por: Belshaw, Robert, et al.
Publicado: (2009)

Characterisation of FEZ1-mediated inhibition of retroviral replication
por: Brown, Craig, et al.
Publicado: (2009)

Challenges and solutions in replicability and provenance tracking for simulation projects
por: Davison, Andrew P
Publicado: (2010)

Developing a framework for replication of research in implementation science
por: Curran, Janet, et al.
Publicado: (2014)

De-Coding the Contributions of the Viral RNAs to Alphaviral Pathogenesis
por: LaPointe, Autumn T., et al.
Publicado: (2021)

P19-38. Safety and protective immunity in Rhesus monkeys immunized with replication-defective HIV/SIV vaccine
por: Tung, F, et al.
Publicado: (2009)

Identifying features of the lentiviral genome crucial for the establishment of latency
por: Ziglio, Serena, et al.
Publicado: (2013)

HIV-1 replication changes the function of the PKR activator PACT
por: Clerzius, Guerline, et al.
Publicado: (2013)

La reanimación cardiopulmonar esencial (RCP-E) y complementaria (RCP-C)
por: Pérez Rubio, María Trinidad, et al.
Publicado: (2021)

A conditionally replicating SIV variant that can be used to study the mechanism of protection conferred by live attenuated SIV vaccines
por: Das, Atze T, et al.
Publicado: (2011)

A dose-escalation clinical trial to evaluate the safety and immunogenicity of a replication-defective HIV-1 vaccine-HIVAX
por: Tung, F, et al.
Publicado: (2012)

Role for Gag-CA Interdomain Linker in Primate Lentiviral Replication
por: Doi, Naoya, et al.
Publicado: (2019)

Forced primer selection modulates HIV-1 replication and stability of the PBS
por: Ni, Na, et al.
Publicado: (2006)

Replication of the association of the COG6 gene with juvenile idiopathic arthritis (JIA)
por: Hinks, A, et al.
Publicado: (2011)

Control of HIV replication by a novel constitutively active ‘super-PRR’
por: Gupta, S, et al.
Publicado: (2012)

The antisense protein of HTLV-2 positively modulates HIV-1 replication
por: Torresilla, Cynthia, et al.
Publicado: (2014)

P02-10. Plant expression of chimeric Gag/gp41 virus-like particles as a mucosally-targeted subunit vaccine against HIV-1
por: Kessans, SA, et al.
Publicado: (2009)

Anti-Alphaviral Alkaloids: Focus on Some Isoquinolines, Indoles and Quinolizidines
por: Sandenon Seteyen, Anne-Laure, et al.
Publicado: (2022)

311. Heterologous immunity and host susceptibility to emerging alphaviral infections
por: Vittor, Amy Y, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_pdincgld2cd8d5398um13e99o8